Cite

1. Farrell PM. The prevalence of cystic fibrosis in the European Union. J Cyst Fibros. 2008;7(5):450-3. DOI: 10.1016/j.jcf.2008.03.00710.1016/j.jcf.2008.03.00718442953Search in Google Scholar

2. Wang Y, Wrennall JA, Cai Z, Li H, Sheppard DN. Understanding how cystic fibrosis mutations disrupt CFTR function: from single molecules to animal models. Int J Biochem Cell Biol. 2014 Jul;52:47-57. DOI: 10.1016/j. biocel.2014.04.001Search in Google Scholar

3. Ong T, Marshall SG, Karczeski BA, et al. Cystic Fibrosis and Congenital Absence of the Vas Deferens. 2001 Mar 26 [Updated 2017 Feb 2]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2020. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1250/Search in Google Scholar

4. Castellani C, Macek M, Cassiman JJ, Duff A, Massie J, ten Kate LP, et al. Benchmarks for Cystic Fibrosis carrier screening: A European consensus document. J Cyst Fibros [Internet]. 2010;9(3):165-78. DOI: 10.1016/j. jcf.2010.02.005Search in Google Scholar

5. Ioannou L, McClaren B, Massie J, Lewis S, Metcalfe S, Forrest L, et al. Population-based carrier screening for cystic fibrosis: a systematic review of 23 years of research. Genet Med. 2014 Mar;16(3):207-16. DOI: 10.1038/gim.2013.12510.1038/gim.2013.12524030436Search in Google Scholar

6. Frenţescu L, Brownsell E, Hinks J, Malone G, Shaw H, Budişan L, et al. The study of cystic fibrosis trans-membrane conductance regulator gene mutations in a group of patients from Romania. J Cyst Fibros. 2008;7(5):423-8. DOI: 10.1016/j.jcf.2008.03.00410.1016/j.jcf.2008.03.00418467194Search in Google Scholar

7. Dobre M, Chesaru B, Romila A, Tutunaru D, Gurău G. Cystic fibrosis in Romanian children [Internet]. 2015 [cited 2020 Apr 3]. Available from: https://www.researchgate.net/publication/279202066_Cystic_fibrosis_in_Romanian_children.Search in Google Scholar

8. Apostol P, Cimponeriu D, Radu I, Gavrila L. The analysis of some CFTR gene mutations in a small group of cf patients from southern part of Romania. Analele Univ din Oradea Fasc Biol [Internet]. 2009;TOM XVI(1):8-11.Search in Google Scholar

9. De Vries HG, Collée JM, De Walle HEK, Van Veldhuizen MHR, Smit Sibinga CT, Scheffer H, et al. Prevalence of ΔF508 cystic fibrosis carriers in The Netherlands: Logistic regression on sex, age, region of residence and number of offspring. Hum Genet. 1996;99(1):74-9. DOI: 10.1007/s00439005031410.1007/s0043900503149003498Search in Google Scholar

10. Norman R, van Gool K, Hall J, Delatycki M, Massie J. Cost-effectiveness of carrier screening for cystic fibrosis in Australia. J Cyst Fibros [Internet]. 2012 Jul [cited 2020 Dec 14];11(4):281-7. DOI: 10.1016/j. jcf.2012.02.007Search in Google Scholar

eISSN:
2284-5623
Language:
English
Publication timeframe:
4 times per year
Journal Subjects:
Life Sciences, Molecular Biology, Biochemistry, Human Biology, Microbiology and Virology